BioLife Solutions to Participate in Upcoming Investor Conferences in May and June 2025

  • BOTHELL, Wash. , May 14, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the company will be participating in the following investor conferences: 22nd Annual Craig-Hallum Institutional Investor Conference May 28, 2025 Minneapolis, MN at the Renaissance Hotel Benchmark 2025 Healthcare House Call Virtual Conference May 29, 2025 Virtual Jefferies Global Life Sciences Conference June 3 – 5, 2025 New York, NY at the Marriott Marquis Wolfe Research Small & Mid-Cap Conference June 5, 2025 New York, NY at Wolfe Headquarters Northland Growth Conference 2025 June 25, 2025 Virtual About BioLife Solutions BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets.